Document Detail


Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans.
MedLine Citation:
PMID:  16717144     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Previous studies suggest that neuronal norepinephrine transporter function may regulate the distribution of sympathetic activity among blood vessels, heart, and kidney; we tested the functional relevance in humans. Sixteen healthy men (26+/-1 years) ingested 8 mg of the selective norepinephrine reuptake transporter inhibitor reboxetine or a matching placebo on 2 separate days in a double-blind, randomized, crossover fashion. We monitored heart rate, thoracic bioimpedance, blood pressure, glomerular filtration rate, and renal blood flow. Ninety minutes after ingestion of the test medication, subjects were tilted to a 45 degrees head-up position, where they remained for an additional 30 minutes. Reboxetine increased supine systolic blood pressure through an increase in cardiac output whereas systemic vascular resistance decreased. Furthermore, reboxetine increased heart rate, particularly with a head-up tilt. Supine plasma renin activity was 0.71+/-0.15 ng angiotensin (Ang)/L per mL/h with placebo and 0.36+/-0.07 ngAng/L per mL/h with reboxetine (P<0.01). Supine plasma Ang II concentrations were also decreased with reboxetine. Both plasma renin activity and Ang II concentrations remained suppressed during head-up tilt. On placebo, renal vascular resistance increased with head-up tilt. The response was abolished with norepinephrine reuptake inhibition. We conclude that norepinephrine reuptake function profoundly influences the distribution of sympathetic activity between the heart, vasculature, and kidney in humans. All of these changes are physiologically relevant because they lead to corresponding changes in organ function.
Authors:
Antje F Mayer; Christoph Schroeder; Karsten Heusser; Jens Tank; André Diedrich; Roland E Schmieder; Friedrich C Luft; Jens Jordan
Related Documents :
11532704 - Validity of microgravity simulation models on earth.
12507804 - Resolution of vital sign instability: an objective measure of medical stability in anor...
12598954 - Association between vasovagal hypotension and low sympathetic neural activity during pr...
10432334 - Pathophysiological basis of orthostatic hypotension in autonomic failure.
11256974 - Relationship between c-reactive protein and intima-media thickness in the carotid and f...
20368244 - Short-term couplings of the cardiovascular system in pregnant women suffering from pre-...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2006-05-22
Journal Detail:
Title:  Hypertension     Volume:  48     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2006 Jul 
Date Detail:
Created Date:  2006-06-23     Completed Date:  2006-07-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  United States    
Other Details:
Languages:  eng     Pagination:  120-6     Citation Subset:  IM    
Affiliation:
Franz-Volhard-Clinical Research Center, Medical Faculty of the Charité, Max-Delbrueck Centrum, and HELIOS Klinikum, Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic Uptake Inhibitors / pharmacology*
Adult
Angiotensin II / blood
Blood Pressure / drug effects
Cross-Over Studies
Double-Blind Method
Glomerular Filtration Rate / drug effects
Heart Rate / drug effects
Hemodynamics / drug effects
Humans
Male
Morpholines / pharmacology*
Norepinephrine / metabolism
Norepinephrine Plasma Membrane Transport Proteins / antagonists & inhibitors*,  metabolism
Posture
Renal Circulation / drug effects
Renin / blood
Sympathetic Nervous System / drug effects*
Chemical
Reg. No./Substance:
0/Adrenergic Uptake Inhibitors; 0/Morpholines; 0/Norepinephrine Plasma Membrane Transport Proteins; 11128-99-7/Angiotensin II; 51-41-2/Norepinephrine; 98769-81-4/reboxetine; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functional noncoding sequences derived from SINEs in the mammalian genome.
Next Document:  Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced ob...